Anders Grubb Selected Research

Cystatin C

1/2022	Large difference but high correlation between creatinine and cystatin C estimated glomerular filtration rate in Mesoamerican sugarcane cutters.
10/2020	Cystatin C Plays a Sex-Dependent Detrimental Role in Experimental Autoimmune Encephalomyelitis.
8/2020	Structural Characterization of Covalently Stabilized Human Cystatin C Oligomers.
12/2019	The domain swapping of human cystatin C induced by synchrotron radiation.
1/2018	Comparison of glomerular filtration rate estimating equations derived from creatinine and cystatin C: validation in the Age, Gene/Environment Susceptibility-Reykjavik elderly cohort.
12/2017	Cystatin C is Indispensable for Evaluation of Kidney Disease.
9/2017	Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells.
1/2017	Cystatin C peptidomimetic derivative with antimicrobial properties as a potential compound against wound infections.
11/2016	The shrunken pore syndrome is associated with declined right ventricular systolic function in a heart failure population - the HARVEST study.
2/2015	Accuracy of GFR estimating equations combining standardized cystatin C and creatinine assays: a cross-sectional study in Sweden.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anders Grubb Research Topics

Disease

7	Chronic Renal Insufficiency 01/2022 - 02/2015
7	Atherosclerosis 01/2021 - 02/2005
5	Kidney Diseases (Kidney Disease) 10/2019 - 01/2010
4	Amyloid Plaque 12/2019 - 07/2004
4	Alzheimer Disease (Alzheimer's Disease) 11/2012 - 01/2006
3	Neoplasms (Cancer) 09/2017 - 03/2006
3	Carcinogenesis 09/2017 - 03/2006
3	Amyloid angiopathy 03/2014 - 12/2011
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 06/2013 - 06/2004
3	Amyloidosis 12/2007 - 06/2004
2	Heart Failure 10/2021 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 08/2004
2	Inflammation (Inflammations) 01/2021 - 04/2011
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 12/2017
2	Rheumatoid Arthritis 03/2011 - 06/2007
2	Arthritis (Polyarthritis) 03/2011 - 05/2004
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2020
1	Multiple Sclerosis 10/2020
1	Proteostasis Deficiencies 08/2020
1	Neuroblastoma 01/2018
1	Breast Neoplasms (Breast Cancer) 09/2017
1	Bone Resorption 01/2017
1	Wound Infection (Wound Infections) 01/2017
1	Acute Kidney Injury (Acute Renal Failure) 02/2016
1	Male Infertility (Male Sterility) 03/2014
1	Pathologic Processes 10/2012
1	Experimental Arthritis 03/2011
1	Hypersensitivity (Allergy) 03/2011
1	Autoimmune Diseases (Autoimmune Disease) 03/2011
1	Carcinoma in Situ 11/2010
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 11/2010
1	Epilepsy (Aura) 03/2010
1	Muscular Atrophy (Muscle Atrophy) 01/2009
1	Hypertension (High Blood Pressure) 01/2009
1	Fatigue 12/2008
1	Wounds and Injuries (Trauma) 06/2007
1	Carcinoma (Carcinomatosis) 03/2006
1	Infections 01/2006
1	Cerebral Hemorrhage 01/2006
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2006
1	Stroke (Strokes) 01/2006
1	Familial Cerebral Amyloid Angiopathy 01/2006
1	Type 2 Hdl Deficiency 01/2006
1	Status Epilepticus (Complex Partial Status Epilepticus) 11/2005
1	Cysts 02/2005
1	Atherosclerotic Plaque (Atheroma) 02/2005

Drug/Important Bio-Agent (IBA)

31	Cystatin CIBA 01/2022 - 09/2003
11	CreatinineIBA 01/2022 - 01/2009
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2004
5	Cysteine Proteinase InhibitorsIBA 10/2020 - 10/2005
5	Amyloid (Amyloid Fibrils)IBA 03/2014 - 01/2006
3	CathepsinsIBA 09/2017 - 03/2006
2	Monoclonal AntibodiesIBA 09/2020 - 12/2011
2	Cysteine (L-Cysteine)FDA Link 09/2017 - 03/2006
2	Peptide Hydrolases (Proteases)FDA Link 09/2017 - 03/2011
2	Protease Inhibitors (Protease Inhibitor)IBA 09/2017 - 02/2005
2	Collagen Type II (Type II Collagen)IBA 03/2011 - 05/2004
2	Apolipoproteins E (ApoE)IBA 10/2005 - 02/2005
2	ApolipoproteinsIBA 10/2005 - 02/2005
1	ProteomeIBA 09/2020
1	AlbuminsIBA 10/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Insulin-Like Growth Factor Binding Protein 6IBA 01/2018
1	FollistatinIBA 01/2018
1	Trefoil Factor-3IBA 01/2018
1	Oncogene Proteins (Oncogene Protein)IBA 09/2017
1	14-3-3 Proteins (14-3-3 Protein)IBA 09/2017
1	LipopolysaccharidesIBA 01/2017
1	PeptidomimeticsIBA 01/2017
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2012
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 10/2012
1	Pharmaceutical PreparationsIBA 12/2011
1	CollagenIBA 03/2011
1	Keratin-14 (Keratin 14)IBA 11/2010
1	Cystatin BIBA 11/2010
1	Natriuretic PeptidesIBA 01/2009
1	Amyloid beta-PeptidesIBA 10/2008
1	Peptides (Polypeptides)IBA 10/2008
1	Cathepsin BIBA 10/2008
1	AntibodiesIBA 06/2007
1	Iohexol (Omnipaque)FDA Link 06/2007
1	EndostatinsIBA 03/2006
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2006
1	Tissue ExtractsIBA 03/2006
1	Insulin (Novolin)FDA Link 03/2006
1	cathepsin SIBA 03/2006
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 03/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2006
1	HDL CholesterolIBA 01/2006
1	Orosomucoid (Seromucoid)IBA 01/2006
1	Serum AlbuminIBA 01/2006
1	Amyloidogenic ProteinsIBA 01/2006
1	CholesterolIBA 01/2006
1	C-Reactive ProteinIBA 01/2006
1	LipidsIBA 02/2005
1	Cysteine Proteases (Cysteine Protease)IBA 02/2005

Therapy/Procedure

1	Patient Readmission 10/2021
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021